Latest On Protalix BioTherapeutics, Inc (PLX):
About Protalix BioTherapeutics, Inc (PLX):
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, rest of Latin America, and internationally. The company offers Elelyso, a plant cell expressed recombinant glucocerebrosidase enzyme for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in phase III clinical trials for the treatment of Fabry diseases; OPRX-106, an orally-delivered protein product candidate for the treatment of inflammatory bowel disease, as well as completed Phase IIa clinical trial for ulcerative colitis patients; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; and PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is headquartered in Karmiel, Israel.
General
- Name Protalix BioTherapeutics, Inc
- Symbol PLX
- Type Common Stock
- Exchange NYSE MKT
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 196
- Last Split Factor1:10
- Last Split Date2019-12-20
- Fiscal Year EndDecember
- IPO Date1998-05-15
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.protalix.com
Valuation
- Forward PE 161.29
- Price/Sales (Trailing 12 Mt.) 1.95
- Enterprise Value Revenue 3.96
- Enterprise Value EBITDA 60.09
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.02
- Profit Margin -11%
- Operating Margin 3%
- Return on Assets 2%
- Revenue 61.16 million
- Earnings Per Share -$0.17
- Revenue Per Share $2.49
- Gross Profit 43.8 million
- Quarterly Earnings Growth -24.3%
Highlights
- Market Capitalization 228.73 million
- EBITDA 3.49 million
- PE Ratio 10.99
- PEG Ratio -0.1
- Analyst Target Price $13
- Book Value Per Share -$0.46
Share Statistics
- Shares Outstanding 45.38 million
- Shares Float 21.89 million
- % Held by Insiders 3284%
- % Held by Institutions 15.89%
- Shares Short 1.46 million
- Shares Short Prior Month 505545
- Short Ratio 0.97
- Short % of Float 3%
- Short % of Shares Outstanding 3%
Technicals
- Beta 2.83
- 52 Week High $7.02
- 52 Week Low $2.11
- 50 Day Moving Average 4.87
- 200 Day Moving Average 3.96
Dividends
- Dividend Date 2019-12-20
- ExDividend Date N/A
- Dividend Yield 0%
Protalix BioTherapeutics, Inc (PLX) Dividend Calendar:
PLX's last dividend payment was made to shareholders on December 20, 2019.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Protalix BioTherapeutics, Inc (PLX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-10-29 | $N/A | -$0.14 | -$0.08 | -75% |
2020-06-30 | 2020-08-10 | $N/A | -$0.13 | -$0.21 | 36.59% |
2020-03-31 | 2020-06-01 | $21.65 million | $0.10 | -$0.30 | 133.33% |
2019-12-31 | 2020-03-12 | $17.76 million | $0.02 | -$0.25 | 108% |
2019-09-30 | 2019-11-07 | $14.25 million | -$0.20 | -$0.35 | 42.86% |
2019-06-30 | 2019-08-08 | $12.25 million | -$0.50 | -$0.30 | -66.67% |
2019-03-31 | 2019-05-06 | $10.44 million | -$0.50 | -$0.25 | -100% |
2018-12-31 | 2019-03-18 | $10.35 million | $0.70 | -$0.45 | 255.56% |
2018-09-30 | 2018-11-07 | $12.34 million | -$1.00 | -$0.40 | -150% |
2018-06-30 | 2018-08-09 | $7 million | -$0.80 | -$0.40 | -100% |
2018-03-31 | 2018-05-09 | $6.71 million | -$0.60 | -$0.90 | 33.33% |
2017-12-31 | 2018-03-06 | $2.47 million | -$1.00 | -$0.60 | -66.67% |
2017-09-30 | 2017-11-08 | $7.53 million | -$0.90 | -$0.45 | -100% |
2017-06-30 | 2017-08-09 | $6.36 million | -$0.06 | $0.65 | -109.23% |
2017-03-31 | 2017-05-10 | $2.89 million | -$4.80 | -$0.90 | -433.33% |
2016-12-31 | 2017-03-16 | $2.08 million | -$0.20 | -$1.10 | 81.82% |
2016-09-30 | 2016-11-09 | $4.67 million | -$0.70 | -$1.00 | 30% |
2016-06-30 | 2016-08-08 | $1.77 million | -$1.10 | -$0.90 | -22.22% |
2016-03-31 | 2016-05-09 | $679000 | -$0.90 | -$0.75 | -20% |
2015-12-31 | 2016-03-08 | $-5349000 | $0.77 | $0.68 | 13.24% |
2015-09-30 | 2015-11-10 | $1.34 million | -$0.04 | -$0.08 | 50% |
2015-06-30 | 2015-08-11 | $4.62 million | -$0.05 | -$0.08 | 37.5% |
2015-03-31 | 2015-05-07 | $5.1 million | -$0.06 | -$0.08 | 25% |
2014-12-31 | 2015-03-12 | $1.38 million | -$0.09 | -$0.04 | -125% |
2014-09-30 | 2014-11-10 | $3.71 million | -$0.09 | -$0.04 | -125% |
2014-06-30 | 2014-08-07 | $2.69 million | -$0.70 | -$0.70 | 0% |
2014-03-31 | 2014-05-08 | $7.38 million | -$0.80 | -$0.43 | -86.05% |
2013-12-31 | 2014-03-13 | $1.12 million | -$1.20 | -$0.32 | -275% |
2013-09-30 | 2013-11-07 | $3.36 million | -$0.60 | -$0.80 | 25% |
2013-06-30 | 2013-08-08 | $3.06 million | -$0.70 | -$0.50 | -40% |
2013-03-31 | 2013-05-09 | $3.97 million | -$0.50 | -$0.65 | 23.08% |
2012-12-31 | 2013-02-28 | $48000 | -$1.10 | -$0.70 | -57.14% |
2012-09-30 | 2012-11-07 | $5.39 million | -$0.60 | -$1.20 | 50% |
2012-06-30 | 2012-08-05 | $25.26 million | $1.00 | -$0.80 | 225% |
2012-03-31 | 2012-05-09 | $3.73 million | -$0.70 | -$0.80 | 12.5% |
2011-12-31 | 2012-02-27 | $689000 | -$1.00 | -$1.00 | 0% |
2011-09-30 | 2011-11-07 | $897000 | -$1.00 | -$1.15 | 13.04% |
2011-06-30 | 2011-08-08 | $-4618000 | -$1.60 | -$1.20 | -33.33% |
2011-03-31 | 2011-05-04 | $6 million | -$0.60 | -$0.62 | 3.23% |
2010-12-31 | 2011-02-23 | $5.78 million | -$1.10 | -$0.62 | -77.42% |
2010-09-30 | 2010-11-08 | $3.18 million | -$0.30 | -$1.06 | 71.7% |
2010-06-30 | 2010-08-05 | $1.14 million | -$1.20 | -$0.84 | -42.86% |
2010-03-31 | 2010-05-10 | $1.14 million | -$1.00 | -$1.03 | 2.91% |
2009-12-31 | 2010-02-26 | $388000 | -$1.90 | $1.15 | -265.22% |
2009-09-30 | 2009-11-09 | $N/A | -$0.80 | -$0.70 | -14.29% |
2009-06-30 | 2009-08-03 | $N/A | -$0.70 | -$0.80 | 12.5% |
2009-03-31 | 2009-05-11 | $N/A | -$0.70 | -$0.80 | 12.5% |
2008-12-31 | 2009-03-06 | $N/A | -$0.90 | -$0.95 | 5.26% |
2008-09-30 | 2008-11-10 | $N/A | -$0.90 | -$0.70 | -28.57% |
2008-06-30 | 2008-09-03 | $N/A | -$0.56 | ||
2008-03-31 | 2008-05-28 | $N/A | -$0.67 | ||
2007-12-31 | 2008-03-17 | $N/A | -$0.70 | -$0.50 | -40% |
2007-09-30 | 2007-11-28 | $N/A | -$0.72 | ||
2007-06-30 | 2007-06-30 | $N/A | -$1.39 | ||
2007-03-31 | 2007-03-31 | $N/A | -$0.54 | ||
2006-12-31 | 2006-12-31 | $N/A | -$0.60 | ||
2006-09-30 | 2006-09-30 | $N/A | -$1.83 | ||
2006-06-30 | 2006-06-30 | $N/A | $0.50 | ||
2006-03-31 | 2006-03-31 | $N/A | -$0.19 | ||
2005-12-31 | 2005-12-31 | $N/A | $10.00 | ||
2005-09-30 | 2005-09-30 | $N/A | -$1.10 | ||
2005-06-30 | 2005-06-30 | $N/A | -$0.44 | ||
2005-03-31 | 2005-03-31 | $N/A | -$0.36 | ||
2004-12-31 | 2004-12-31 | $N/A | -$1.08 | ||
2004-09-30 | 2004-09-30 | $N/A | -$1.48 | ||
2004-06-30 | 2004-06-30 | $N/A | -$2.01 | ||
2004-03-31 | 2004-03-31 | $N/A | -$0.92 | ||
2003-12-31 | 2003-12-31 | $N/A | -$1.58 | ||
2003-09-30 | 2003-09-30 | $N/A | -$1.11 | ||
2003-06-30 | 2003-06-30 | $N/A | -$1.02 | ||
2003-03-31 | 2003-03-31 | $N/A | -$1.11 | ||
2002-09-30 | 2002-09-30 | $N/A | -$1.10 | ||
2002-06-30 | 2002-06-30 | $N/A | -$1.10 | ||
2002-03-31 | 2002-03-31 | $N/A | -$1.23 | ||
2001-09-30 | 2001-09-30 | $N/A | -$1.66 | ||
2001-06-30 | 2001-06-30 | $N/A | -$1.67 | ||
2001-03-31 | 2001-03-31 | $N/A | -$4.38 |
Protalix BioTherapeutics, Inc (PLX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Protalix BioTherapeutics, Inc (PLX) Chart:
Protalix BioTherapeutics, Inc (PLX) News:
Below you will find a list of latest news for Protalix BioTherapeutics, Inc (PLX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Protalix BioTherapeutics, Inc (PLX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-04-19 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-04-19 | 1.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 2.5 | 0.05 | CALL | 0 | 9 | 0 | FALSE | 0 | 0 |
2024-04-19 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 1 | 0.05 | PUT | 0 | 20 | 0 | FALSE | 0 | 0 |
2024-04-19 | 1.5 | 0 | PUT | 0 | 0 | 152.85 | TRUE | 0 | 0 |
2024-04-19 | 2.5 | 1 | PUT | 0 | 1 | 462.7 | TRUE | 0 | 0 |
2024-04-19 | 5 | 0 | PUT | 0 | 0 | 485.71 | TRUE | 0 | 0 |
2024-04-19 | 7.5 | 0 | PUT | 0 | 0 | 444.54 | TRUE | 0 | 0 |
2024-05-17 | 1 | 0.3 | CALL | 3 | 434 | 81.34 | TRUE | 0.3 | 0 |
2024-05-17 | 2 | 0.05 | CALL | 0 | 1206 | 0 | FALSE | 0 | 0 |
2024-05-17 | 3 | 0.1 | CALL | 0 | 131 | 0 | FALSE | 0 | 0 |
2024-05-17 | 4 | 0.05 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-05-17 | 5 | 0.05 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
2024-05-17 | 1 | 0.06 | PUT | 0 | 26 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2 | 0.6 | PUT | 0 | 105 | 125.95 | TRUE | 0 | 0 |
2024-05-17 | 3 | 0 | PUT | 0 | 0 | 340.59 | TRUE | 0 | 0 |
2024-05-17 | 4 | 2.78 | PUT | 0 | 1 | 0 | TRUE | 0 | 0 |
2024-05-17 | 5 | 0 | PUT | 0 | 0 | 402.93 | TRUE | 0 | 0 |
2024-08-16 | 0.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-08-16 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-08-16 | 1.5 | 0.2 | CALL | 3 | 148 | 89.33 | FALSE | 0.2 | 0 |
2024-08-16 | 2.5 | 0.13 | CALL | 0 | 562 | 0 | FALSE | 0 | 0 |
2024-08-16 | 5 | 0.05 | CALL | 0 | 7 | 0 | FALSE | 0 | 0 |
2024-08-16 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-08-16 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-08-16 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-08-16 | 1.5 | 0.4 | PUT | 0 | 90 | 65.29 | TRUE | 0 | 0 |
2024-08-16 | 2.5 | 0 | PUT | 0 | 0 | 103.48 | TRUE | 0 | 0 |
2024-08-16 | 5 | 0 | PUT | 0 | 0 | 189.75 | TRUE | 0 | 0 |
2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 347.55 | TRUE | 0 | 0 |
2024-11-15 | 1 | 0.5 | CALL | 1 | 13 | 99.43 | TRUE | 0.05 | 0.11 |
2024-11-15 | 1.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-11-15 | 2.5 | 0 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
2024-11-15 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-11-15 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-11-15 | 1 | 0 | PUT | 0 | 0 | 125.92 | FALSE | 0 | 0 |
2024-11-15 | 1.5 | 0 | PUT | 0 | 0 | 104.44 | TRUE | 0 | 0 |
2024-11-15 | 2.5 | 0 | PUT | 0 | 0 | 93.73 | TRUE | 0 | 0 |
2024-11-15 | 5 | 0 | PUT | 0 | 0 | 184.72 | TRUE | 0 | 0 |
2024-11-15 | 7.5 | 0 | PUT | 0 | 0 | 229.95 | TRUE | 0 | 0 |
Latest PLX Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:15 PM EST | 3 | $1.08 |
Jun 13, 2022 7:58 PM EST | 20 | $1.085 |
Jun 13, 2022 7:58 PM EST | 20 | $1.085 |
Protalix BioTherapeutics, Inc (PLX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1006281/000110465920072466/0001104659-20-072466-index.htm |
2018-12-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1006281/000000000018037154/0000000000-18-037154-index.htm |
2019-02-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1006281/000000000019002296/0000000000-19-002296-index.htm |
2019-03-15 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1006281/000000000019004851/0000000000-19-004851-index.htm |
2019-04-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1006281/000000000019006718/0000000000-19-006718-index.htm |
2020-04-22 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1006281/000000000020003470/0000000000-20-003470-index.htm |
2020-03-23 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000090266420001614/0000902664-20-001614-index.htm |
2019-10-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1006281/000110465919054172/0001104659-19-054172-index.htm |
2019-10-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465919054507/0001104659-19-054507-index.htm |
2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465919060801/0001104659-19-060801-index.htm |
2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000110465919060804/0001104659-19-060804-index.htm |
2019-11-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1006281/000110465919062654/0001104659-19-062654-index.htm |
2019-11-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1006281/000110465919064785/0001104659-19-064785-index.htm |
2019-11-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465919064875/0001104659-19-064875-index.htm |
2019-11-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1006281/000110465919067679/0001104659-19-067679-index.htm |
2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465919070966/0001104659-19-070966-index.htm |
2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465919074052/0001104659-19-074052-index.htm |
2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465919074602/0001104659-19-074602-index.htm |
2020-01-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920000972/0001104659-20-000972-index.htm |
2020-01-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920000974/0001104659-20-000974-index.htm |
2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920005965/0001104659-20-005965-index.htm |
2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920005967/0001104659-20-005967-index.htm |
2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920005970/0001104659-20-005970-index.htm |
2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920005971/0001104659-20-005971-index.htm |
2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920005972/0001104659-20-005972-index.htm |
2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920011315/0001104659-20-011315-index.htm |
2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920011603/0001104659-20-011603-index.htm |
2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920013512/0001104659-20-013512-index.htm |
2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920032169/0001104659-20-032169-index.htm |
2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920032178/0001104659-20-032178-index.htm |
2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1006281/000110465920032540/0001104659-20-032540-index.htm |
2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920035325/0001104659-20-035325-index.htm |
2020-03-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000110465920038290/0001104659-20-038290-index.htm |
2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920045926/0001104659-20-045926-index.htm |
2020-04-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1006281/000110465920046926/0001104659-20-046926-index.htm |
2020-04-17 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1006281/000110465920048223/0001104659-20-048223-index.htm |
2020-04-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1006281/000110465920051570/0001104659-20-051570-index.htm |
2020-04-29 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1006281/000110465920053547/0001104659-20-053547-index.htm |
2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920059038/0001104659-20-059038-index.htm |
2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920059085/0001104659-20-059085-index.htm |
2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920066624/0001104659-20-066624-index.htm |
2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920067973/0001104659-20-067973-index.htm |
2020-06-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000110465920067982/0001104659-20-067982-index.htm |
2020-06-01 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000110465920068485/0001104659-20-068485-index.htm |
2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920070904/0001104659-20-070904-index.htm |
2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920070906/0001104659-20-070906-index.htm |
2020-06-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1006281/000110465920072466/0001104659-20-072466-index.htm |
2020-07-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920082114/0001104659-20-082114-index.htm |
2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920082116/0001104659-20-082116-index.htm |
2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920092367/0001104659-20-092367-index.htm |
2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000110465920092375/0001104659-20-092375-index.htm |
2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920092996/0001104659-20-092996-index.htm |
2020-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920094751/0001104659-20-094751-index.htm |
2020-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920094753/0001104659-20-094753-index.htm |
2020-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920094755/0001104659-20-094755-index.htm |
2020-08-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920095623/0001104659-20-095623-index.htm |
2020-08-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000110465920095626/0001104659-20-095626-index.htm |
2020-09-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920102834/0001104659-20-102834-index.htm |
2020-10-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1006281/000110465920111156/0001104659-20-111156-index.htm |
2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000110465920111165/0001104659-20-111165-index.htm |
2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000114036119002765/0001140361-19-002765-index.htm |
2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000114036120002573/0001140361-20-002573-index.htm |
2018-02-23 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1006281/000114420418010571/0001144204-18-010571-index.htm |
2018-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418012946/0001144204-18-012946-index.htm |
2018-03-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1006281/000114420418013053/0001144204-18-013053-index.htm |
2018-03-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418016178/0001144204-18-016178-index.htm |
2018-03-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1006281/000114420418016715/0001144204-18-016715-index.htm |
2018-04-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1006281/000114420418018393/0001144204-18-018393-index.htm |
2018-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418020721/0001144204-18-020721-index.htm |
2018-04-18 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1006281/000114420418021154/0001144204-18-021154-index.htm |
2018-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418026337/0001144204-18-026337-index.htm |
2018-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000114420418026625/0001144204-18-026625-index.htm |
2018-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418028177/0001144204-18-028177-index.htm |
2018-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418030793/0001144204-18-030793-index.htm |
2018-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418031991/0001144204-18-031991-index.htm |
2018-06-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1006281/000114420418033540/0001144204-18-033540-index.htm |
2018-06-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420418033545/0001144204-18-033545-index.htm |
2018-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418039629/0001144204-18-039629-index.htm |
2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418042980/0001144204-18-042980-index.htm |
2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000114420418043286/0001144204-18-043286-index.htm |
2018-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418043714/0001144204-18-043714-index.htm |
2018-08-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420418043724/0001144204-18-043724-index.htm |
2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420418049515/0001144204-18-049515-index.htm |
2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420418049517/0001144204-18-049517-index.htm |
2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420418049521/0001144204-18-049521-index.htm |
2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420418049522/0001144204-18-049522-index.htm |
2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420418049524/0001144204-18-049524-index.htm |
2018-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418050260/0001144204-18-050260-index.htm |
2018-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418052605/0001144204-18-052605-index.htm |
2018-10-05 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1006281/000114420418052765/0001144204-18-052765-index.htm |
2018-10-17 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1006281/000114420418054229/0001144204-18-054229-index.htm |
2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418057755/0001144204-18-057755-index.htm |
2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000114420418057990/0001144204-18-057990-index.htm |
2018-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418064451/0001144204-18-064451-index.htm |
2018-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420418064759/0001144204-18-064759-index.htm |
2018-12-19 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1006281/000114420418065270/0001144204-18-065270-index.htm |
2018-12-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1006281/000114420418066309/0001144204-18-066309-index.htm |
2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419000672/0001144204-19-000672-index.htm |
2019-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419001350/0001144204-19-001350-index.htm |
2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419004918/0001144204-19-004918-index.htm |
2019-03-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1006281/000114420419013136/0001144204-19-013136-index.htm |
2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419014447/0001144204-19-014447-index.htm |
2019-03-18 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000114420419014450/0001144204-19-014450-index.htm |
2019-03-18 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000114420419014453/0001144204-19-014453-index.htm |
2019-03-18 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000114420419014455/0001144204-19-014455-index.htm |
2019-03-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1006281/000114420419014464/0001144204-19-014464-index.htm |
2019-03-29 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1006281/000114420419016978/0001144204-19-016978-index.htm |
2019-04-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1006281/000114420419018975/0001144204-19-018975-index.htm |
2019-04-12 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1006281/000114420419019545/0001144204-19-019545-index.htm |
2019-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419023738/0001144204-19-023738-index.htm |
2019-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000114420419023895/0001144204-19-023895-index.htm |
2019-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419027423/0001144204-19-027423-index.htm |
2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419029036/0001144204-19-029036-index.htm |
2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419029957/0001144204-19-029957-index.htm |
2019-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419031092/0001144204-19-031092-index.htm |
2019-07-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420419033653/0001144204-19-033653-index.htm |
2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420419033654/0001144204-19-033654-index.htm |
2019-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419035361/0001144204-19-035361-index.htm |
2019-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419036350/0001144204-19-036350-index.htm |
2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419038367/0001144204-19-038367-index.htm |
2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000114420419038552/0001144204-19-038552-index.htm |
2019-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419039539/0001144204-19-039539-index.htm |
2019-08-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419043024/0001144204-19-043024-index.htm |
2019-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000114420419045689/0001144204-19-045689-index.htm |
2019-09-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420419045805/0001144204-19-045805-index.htm |
2019-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1006281/000114420419045806/0001144204-19-045806-index.htm |
2019-10-04 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1006281/000114420419047387/0001144204-19-047387-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000121390019002214/0001213900-19-002214-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000121390019002223/0001213900-19-002223-index.htm |
2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000121390020003571/0001213900-20-003571-index.htm |
2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000121390020003584/0001213900-20-003584-index.htm |
2020-03-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000121390020005790/0001213900-20-005790-index.htm |
2020-03-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1006281/000121390020007898/0001213900-20-007898-index.htm |
2020-10-23 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000155837020011697/0001558370-20-011697-index.htm |
2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1006281/000155837020011970/0001558370-20-011970-index.htm |
2020-10-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1006281/000155837020011974/0001558370-20-011974-index.htm |
2018-03-06 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1006281/000157104918000157/0001571049-18-000157-index.htm |
2019-04-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1006281/999999999519000696/9999999995-19-000696-index.htm |
2020-04-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1006281/999999999520000909/9999999995-20-000909-index.htm |
2018-04-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1006281/999999999718004151/9999999997-18-004151-index.htm |
2018-12-04 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1006281/999999999718009272/9999999997-18-009272-index.htm |
2019-12-17 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1006281/999999999719007896/9999999997-19-007896-index.htm |
Protalix BioTherapeutics, Inc (PLX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Protalix BioTherapeutics, Inc (PLX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 3284%Institutional Ownership: 1589%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-08-11 | Eyal Rubin | Sr. VP and CFO | Buy | 246,146.00 | 246,146.00 | https://www.sec.gov/Archives/edgar/data/1006281/000110465920094755/0001104659-20-094755-index.htm | ||
2020-08-11 | Dror Bashan | President and CEO | Buy | 447,927.00 | 447,927.00 | https://www.sec.gov/Archives/edgar/data/1006281/000110465920094753/0001104659-20-094753-index.htm | ||
2020-04-07 | Aharon Schwartz | Director | Buy | 64,000.00 | 2.43 | 155,264.00 | 64,000.00 | https://www.sec.gov/Archives/edgar/data/1006281/000110465920045926/0001104659-20-045926-index.htm |